Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study

Supportive Care in Cancer

Volumn 23, Issue 5, 2015, Pages 1233-1236

  Coller, Janet K ^a   White, Imogen A ^b   Logan, Richard M ^a   Tuke, Jonathan ^a   Richards, Alison M ^c   Mead, Kelly R ^c   Karapetis, Christos S ^c,d   Bowen, Joanne M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

5 fluorouracil; Chemotherapy induced gastrointestinal toxicity; Cytokines; Predictive genetic model; Toll like receptors

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; FLUOROURACIL; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

AGED; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; GENE LOCUS; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALE; MIDDLE AGED; NEOPLASMS; PATHOLOGY; PILOT STUDY; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTOKINES; FEMALE; FLUOROURACIL; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; GENETIC LOCI; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS; PILOT PROJECTS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84931069597     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2481-z     Document Type: Article

References (12)

1. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB, (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025
2. Sonis ST (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5(9 Suppl 4):3–11
3. Stringer AM, Al-Dasooqi N, Bowen JM, Tan TH, Radazum M, Logan RM, Mayo B, Keefe DMK, Gibson RJ (2013) Potential biomarkers of chemotherapy-induced diarrhea: a clinical study of intestinal microbiome alterations; intestinal inflammation and circulating matrix metalloproteinases. Support Care Cancer 21:1843–1852
4. Carlotto A, Hogsett VL, Mairorini EM, Razulis JG, Sonis ST (2013) The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics 31:753–766
5. Logan RM, Stringer AM (2008) Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7:1139–1145
6. Morales-Rojas T, Viera N, Moron-Medina A, Alvarez CJ, Alvarez A (2012) Proinflammatory cytokines during the initial phase of oral mucositis in patients with acute lymphoblastic leukaemia. Int J Paediatr Dent 22:191–196
7. van der Welden W (2011) Mucosal barrier injury, innate immunity, and stem cell transplantation. Radboud University, Nijmegen Medical Centre, Nijmegen
8. Cortejoso L, Lopez-Fernandez LA (2012) Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients. Pharmacogenomics 13:1173–1191
9. Sakamoto K, Oka M, Yoshino S, Hazama S, Abe T, Okayama N, Hinoda Y (2006) Relation between cytokine promoter gene polymorphism and toxicity of 5-fluorouracil plus cisplatin chemotherapy. Oncol Rep 16:381–387
10. Bogunia-Kubik K, Polak M, Lange A (2003) TNF polymorphisms are associated with toxic but not with aGVHD complications in the recipients of allogenic sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 32:617–622
11. R Core Team (2013) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
12. Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA (2011) The role of polymorphisms in toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 130:547–561